29 Sep 2023
2023 October Price Disclosure Cycle – Patient savings
2023 October Price Disclosure Cycle – Patient savings
01 Oct 2023
1 October 2023 designated brand list – minimum stockholding requirements
1 October 2023 designated brand list – minimum stockholding requirements
27 Sep 2023
Updated Agenda for November 2023 PBAC Meeting – 25 September 2023
Updated Agenda for November 2023 PBAC Meeting – 25 September 2023
26 Sep 2023
Updates to the HTA Policy and Methods Review Reference Committee – 26 September 2023
Updates to the HTA Policy and Methods Review Reference Committee – 26 September 2023
22 Sep 2023
Updates to the Health Technology Assessment Policy and Methods Review Reference Committee – 22 September 2023
Updates to the Health Technology Assessment Policy and Methods Review Reference Committee – 22 September 2023
15 Sep 2023
PBS subsidy arrangements for vigabatrin SSSI
PBS subsidy arrangements for vigabatrin SSSI
15 Sep 2023
Updates to the Health Technology Assessment Policy and Methods Review Reference Committee
Updates to the Health Technology Assessment Policy and Methods Review Reference Committee
14 Sep 2023
Updated Agenda for November 2023 PBAC Meeting – 14 September 2023
Updated Agenda for November 2023 PBAC Meeting – 14 September 2023
08 Sep 2023
Updates to the Health Technology Assessment Policy and Methods Review Reference Committee – September 2023
Updates to the Health Technology Assessment Policy and Methods Review Reference Committee – September 2023
08 Sep 2023
Review of cancer related surrogate outcomes used for Pharmaceutical Benefits Advisory Committee (PBAC) decision making
Review of cancer related surrogate outcomes used for Pharmaceutical Benefits Advisory Committee (PBAC) decision making